Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Clinical trial NCT03376659 · TERMINATED

Trial details

NCT number: NCT03376659
Sponsor: Georgetown University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Colorectal Adenocarcinoma Pancreatic Adenocarcinoma Metastatic Pancreatic Cancer

Start date: 2018-08-08
Primary completion: 2021-08-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.